2012

• Wong, G., Howard, K., Chapman, J., Pollock, C., Chadban, S., Salkeld, G., Tong, A., Williams, N., Webster, A., Craig, J. (2012), How do people with chronic kidney disease value cancer-related quality of life?. Nephrology. 17(1), 32-41. [Abstract]

2011

• Howard, K., Salkeld, G., Pignone, M., Hewett, P., Cheung, P., Olsen, J., Clapton, W., Roberts-Thomson, I. (2011), Preferences for CT Colonography and Colonoscopy as Diagnostic Tests for Colorectal Cancer: A Discrete Choice Experiment. Value in Health. 14(8), 1146-1152. [Abstract]
• Yin, J., Wang, H., Skinner, S., Salkeld, G., Booy, R. (2011), Assessing seasonal vaccine-related cross-protection from 2009 pandemic H1N1 influenza through teacher absenteeism. Australian and New Zealand Journal of Public Health. , 393-394. [Abstract]
• Flitcroft, K., Gillespie, J., Salkeld, G., Carter, S., Trevena, L. (2011), Getting evidence into policy: The need for deliberative strategies?. Social science & medicine. 72(7), 1039-0146. [Abstract]
• Pignone, M., Flitcroft, K., Howard, K., Trevena, L., Salkeld, G., St John, D. (2011), Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia. The Medical Journal of Australia. 194(4), 180-185. [Abstract]
• Doran, E., Robertson, J., Salkeld, G. (2011), Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability. Australian Health Review. 35(1), 37-44. [Abstract]
• Flitcroft, K., Gillespie, J., Carter, S., Trevena, L., Salkeld, G. (2011), When good evidence is not enough: the role of context in bowel cancer screening policy in New Zealand. Evidence & Policy: A Journal of Research, Debate and Practice. 7(3), 307-326.
• Flitcroft, K., St John, D., Howard, K., Carter, S., Pignone, M., Salkeld, G., Trevena, L. (2011), A comparative case study of bowel cancer screening in the UK and Australia: evidence lost in translation?. Journal of medical screening. 18(4), 193-203. [Abstract]
• Cunich, M., Salkeld, G., Dowie, J., Henderson, J., Bayram, C., Britt, H., Howard, K. (2011), Integrating evidence and individual preferences using a web-based multi-criteria decision analytic tool: an application to prostate cancer screening. The patient. 4(3), 153-62. [Abstract]

2010

• Flitcroft, K., Salkeld, G., Gillespie, J., Trevena, L., Irwig, L. (2010), Fifteen years of bowel cancer screening policy in Australia: putting evidence into practice?. Medical Journal of Australia. 193(1), 37-42. [Abstract]
• Chim, L., Kelly, P., Salkeld, G., Stockler, M. (2010), Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?. PharmacoEconomics. 28(6), 463-75. [Abstract]
• Howard, K., White, S., Salkeld, G., McDonald, S., Craig, J., Chadban, S., Cass, A. (2010), Cost-Effectiveness of Screening and Optimal Management for Diabetes, Hypertension, and Chronic Kidney Disease: A Modeled Analysis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 13(0), 196-208. [Abstract]

2009

• Masya, L., Young, J., Solomon, M., Harrison, J., Dennis, R., Salkeld, G. (2009), Preferences for outcomes of treatment for rectal cancer: patient and clinician utilities and their application in an interactive computer-based decision aid. Diseases of the Colon and Rectum. 52(12), 1994-2002. [Abstract]
• Harrison, J., Masya, L., Butow, P., Solomon, M., Young, J., Salkeld, G., Whelan, T. (2009), Implementing patient decision support tools: moving beyond academia?. Patient education and counseling. 76(1), 120-125. [Abstract]
• Howard, K., Salkeld, G., White, S., McDonald, S., Chadban, S., Craig, J., Cass, A. (2009), The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton, Vic.). 14(1), 123-32. [Abstract]
• Howard, K., Salkeld, G. (2009), Does Attribute Framing in Discrete Choice Experiments Influence Willingness to Pay? Results from a Discrete Choice Experiment in Screening for Colorectal Cancer. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12(2), 354-63. [Abstract]

2008

• Mackenzie, R., Chapman, S., Salkeld, G., Holding, S. (2008), Media influence on Herceptin subsidization in Australia: application of the rule of rescue?. Journal of the Royal Society of Medicine. 101(6), 305-312. [Abstract]
• Young, J., Solomon, M., Harrison, J., Salkeld, G., Butow, P. (2008), Measuring patient preference and surgeon choice. Surgery. 143(5), 582-588. [Abstract]
• Howard, K., Salkeld, G., McCaffery, K., Irwig, L. (2008), HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?. Health economics. 17(0), 593-605. [Abstract]
• Harrison, J., Solomon, M., Young, J., Meagher, A., Butow, P., Salkeld, G., Hruby, G., Clarke, S. (2008), Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer. Archives of Surgery. 143(4), 389-394. [Abstract]
• Howard, K., Salkeld, G., White, S., Chadban, S., Craig, J., Cass, A., McDonald, S., Perkovic, V. (2008), Cost effectiveness of screening for the early diagnosis and treatment of risk factors for chronic kidney disease: a Markov Monte Carlo microsimulation using marck-E (model for the assessment of risk factors for chronic kidney disease - economics). United States: Wiley-Blackwell Publishing, .
• Entwistle, V., Carter, S., Trevena, L., Flitcroft, K., Irwig, L., McCaffery, K., Salkeld, G. (2008), Communicating about screening. BMJ. 337(0), a1591. [Abstract]
• Lee, B., King, M., Simpson, J., Haran, M., Stockler, M., Marial, O., Salkeld, G. (2008), Validity, Responsiveness, and Minimal Important Difference for the SF-6D Health Utility Scale in a Spinal Cord Injured Population. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 11(0), 680-8. [Abstract]

2007

• Harrison, J., Solomon, M., Young, J., Meagher, A., Hruby, G., Salkeld, G., Clarke, S. (2007), Surgical and oncology trials for rectal cancer: Who will participate?. Surgery. 142(1), 94-101. [Abstract]
• Salkeld, G., Henry, D., Hill, S., Lang, D., Freemantle, N., D'Assunção, J. (2007), What drives health-care spending priorities? An international survey of health-care professionals. PLoS medicine. 4(2), e94. [Abstract]

2006

• Walleser, S., Salkeld, G., Donovan, B. (2006), The cost effectiveness of screening for genital Chlamydia trachomatis infection in Australia. Sexual Health. 3(4), 225-34. [Abstract]
• Butow, P., Solomon, M., Young, J., Whelan, T., Salkeld, G., Wilson, K., Harrison, J., Hruby, G., Mansour, O., Kennedy, N., Tattersall, M. (2006), Consumer impact of an interactive decision aid for rectal cancer patients offered adjuvant therapy. Colorectal Disease. 8(8), 676-682. [Abstract]
• Salkeld, G., Young, J., Solomon, M. (2006), A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Medical Journal of Australia. 185(4), 239-239. [Abstract]
• Salkeld, G., Young, J., Solomon, M. (2006), Consumer choice and the National Bowel Cancer Screening Program. Medical Journal of Australia. 184(11), 541-542. [Abstract]
• Salkeld, G. (2006), The public financing of pharmaceuticals: An economic approach. Australian and New Zealand Journal of Public Health. 30(3), 293-294. [Abstract]
• Irwig, L., McCaffery, K., Salkeld, G., Bossuyt, P. (2006), Informed choice for screening: implications for evaluation. BMJ (Clinical research ed.). 332(7550), 1148-50. [Abstract]
• Morris, J., Roberts, C., Crowther, C., Buchanan, S., Henderson-Smart, D., Salkeld, G. (2006), Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) Trial [ISRCTN44485060]. BMC pregnancy and childbirth. 6, 9. [Abstract]